Pfizer's stock rose 8.03%, despite bearish technicals and mixed analyst ratings. Technical indicators signal a bearish ...

Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. The FLOTILLA Study, officially titled ‘ENCORAFENIB/BINIMETINIB MASTER ...

Pfizer Inc. has just upgraded its 2025 earnings forecast, fueling a bullish sentiment among analysts. After its Q2 earnings ...

Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

These five large-cap value dividend stocks look poised to provide some second-half gains with steady ultra-high-yield ...

Volatility: Blue chip stocks are usually less volatile than other stocks.

Pfizer Inc. (NYSE: PFE) delivered a stronger-than-anticipated second-quarter performance, beating analyst estimates and ...

Pfizer Inc. (NYSE: PFE) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 5, the ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...